Advertisement Feature
The Life Sciences Sector in Malta The most developed sector in the life sciences area in Malta is the production of generic pharmaceuticals. Malta also houses a number of companies operating in sensitive medical devices operations, such as Baxter and Cardinal Health. In order to encourage R&D, ME has developed the Life
Sciences Park, located alongside Malta’s main general hospital, university and medical school. This park houses companies such as Alvogen, engaged in supply chain management, intellectual property portfolio management, technology transfer services, quality control and global finance functions. Any pharmaceutical company manufacturing in Malta can also
make use of the services of the Malta Medicines Authority, which offers efficient and cost effective services and guidance as well as certification of GMPs. The Authority acts as a Reference Authority within the European Union. Today, the Authority is also one of the first eight European Inspectorates to be recognised by the US Food and Drug Administration (US FDA). In 2018, Malta regulated the production of medical cannabis
and today some of the most important manufacturers in the area of medical cannabis are setting up their own facilities in Malta. ME is now working to attract companies which will support manufacturers and can offer their products and services to other European jurisdictions.
The Education Industry in Malta While Malta is well known as a centre for the teaching of English as a foreign language, the country has been identified as an ideal base for universities catering for the large MENA region. These includes universities like Barts and the London School of Medicine and Dentistry, Queen Mary University of London which offers undergraduate medical courses mainly to foreign students. Their new campus in Gozo was inaugurated in November 2019, with state-of-the-art facilities for teaching and research activities.
TESTIMONIAL
“Aurobindo has been operating from Malta since 2007 and today employs 175 full time employees. Malta offers stability, reliability and quality, a low risk country offering high reward investment opportunities.”.
Frederick Schembri – Managing Director, Aurobindo Malta
TESTIMONIAL
“Malta’s strategic location and reliable links with the rest of the region make it a great place in which to invest. Queen Mary University of London is pleased to be working with partners across the region to establish the branch medical school in Malta of Barts and The London School of Medicine, our faculty of medicine and dentistry. Our aims align with Malta’s ambition to become a major international venue for medical activity.”
Professor Anthony Warrens – Dean for Education, Barts & the London School of Medicine and Dentistry, Queen Mary University of London
46 CHAMBERLINK February 2020 Malta Life Sciences Park
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104
